ArticleDiabetes care2021

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.

Anna R Kahkoska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.